June-Horng Lue Selected Research

June-Horng Lue Research Topics

Disease

8	Neuralgia (Stump Neuralgia) 11/2020 - 09/2009
5	Hyperalgesia 01/2018 - 09/2009
4	Hypersensitivity (Allergy) 01/2018 - 09/2009
3	Hypoxia (Hypoxemia) 09/2005 - 02/2003
2	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 11/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2018 - 05/2013
2	Peripheral Nerve Injuries 11/2018 - 09/2009
2	Ganglion Cysts (Ganglion) 12/2010 - 01/2010
1	Hyperglycemia 01/2020
1	Sepsis (Septicemia) 01/2020
1	Sepsis-Associated Encephalopathy 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 03/2012
1	Type 2 Diabetes Mellitus (MODY) 03/2012
1	Neointima 02/2012
1	Pain (Aches) 01/2012
1	Crush Injuries 12/2009
1	Ototoxicity 02/2007

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 11/2020 - 12/2016
3	Lidocaine (Xylocaine)FDA LinkGeneric 01/2012 - 09/2009
3	Neuropeptide YIBA 01/2012 - 09/2009
2	Mitogen-Activated Protein KinasesIBA 11/2020 - 01/2020
2	MelatoninIBA 11/2020 - 09/2005
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2020 - 05/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 12/2010 - 01/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2010 - 02/2003
2	NADP (NADPH)IBA 09/2005 - 02/2003
1	Prazosin (Minipress)FDA LinkGeneric 11/2020
1	4-phenyl-2-propionamidotetralineIBA 11/2020
1	Melatonin Receptors (Melatonin Receptor)IBA 11/2020
1	MT1 Melatonin ReceptorIBA 11/2020
1	MT2 Melatonin ReceptorIBA 11/2020
1	Glial Fibrillary Acidic ProteinIBA 11/2020
1	Insulin (Novolin)FDA Link 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2018
1	Glutamic Acid (Glutamate)FDA Link 11/2018
1	Therapeutic UsesIBA 11/2018
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2018
1	Erythropoietin FDA Link 11/2018
1	Small Interfering RNA (siRNA)IBA 11/2018
1	Neuroprotective AgentsIBA 11/2018
1	Galanin Receptors (Galanin Receptor)IBA 01/2018
1	galanin (2-11)-amideIBA 01/2018
1	Pregnanolone (Allopregnanolone)IBA 12/2016
1	MedroxyprogesteroneIBA 12/2016
1	BicucullineIBA 12/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2016
1	Phosphotransferases (Kinase)IBA 12/2016
1	NeurosteroidsIBA 12/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2016
1	phaclofenIBA 12/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2013
1	arginine methyl esterIBA 05/2013
1	S-Nitroso-N-AcetylpenicillamineIBA 05/2013
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2013
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2013
1	resiniferatoxinIBA 05/2012
1	Purinergic P2X3 ReceptorsIBA 05/2012
1	A-317491IBA 05/2012
1	2',3'-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphateIBA 05/2012
1	Capsaicin (Zostrix)FDA Link 05/2012
1	2-chloro-5-nitrobenzanilideIBA 02/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Substance PIBA 12/2010
1	Clonidine (ST 155)FDA LinkGeneric 01/2010
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2010
1	Voltage-Gated Sodium ChannelsIBA 01/2010
1	fluorocitrateIBA 01/2010
1	Nerve Growth Factor (NGF)IBA 12/2009
1	4-methylcatecholIBA 12/2009
1	Indicators and Reagents (Reagents)IBA 09/2009
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 09/2009
1	AminoglycosidesIBA 02/2007
1	Calcitonin Gene-Related PeptideIBA 12/2004
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 12/2004
1	NMDA receptor A1IBA 02/2003

Therapy/Procedure

2	Glycemic Control 01/2020 - 03/2012
2	Denervation 05/2012 - 03/2012
1	Ligation 01/2020
1	Punctures 01/2020
1	Axotomy 12/2004